V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330004513 | 330002189 | 1.78 | 73.5 | Adjuvant (A) | 2016-09-16 | 2016-10-17 | R Chlorambucil | 02 | N | 330018515 | DOCETAXEL |
| 330004514 | 330002189 | 1.8 | 65.8 | Curative (C) | 2017-04-15 | 2017-04-22 | Cisplatin + Pemetrexed | N | N | 330018515 | EVEROLIMUS |
| 330004515 | 330002189 | 1.6 | 68 | Adjuvant (A) | 2014-07-22 | 2014-07-23 | Methotrexate intrathecal | Y | N | 330018515 | CAPECITABINE + OXALIPLATIN |
| 330004516 | 330002189 | 1.59 | 12.8 | Adjuvant (A) | 2015-01-29 | 2015-05-12 | VAI (Ifos 3g/m2) | N | N | 330018515 | VIDE |
| 330004517 | 330002189 | 1.75 | 66 | Curative (C) | 2013-08-18 | 2013-08-28 | Topotecan (intravenous) | N | N | 330018515 | TEMOZOLOMIDE |
| 330004518 | 330012964 | 1.78 | 0 | Palliative (P) | 2013-11-11 | 2013-11-26 | Cytarabine Low Dose | N | N | 330018552 | CARBOPLATIN + RT |
| 330004519 | 330012964 | null | 24.9 | 4 | 2015-03-08 | 2015-03-24 | ALL UKALL2011 IndB Std Dex (PegAsp) | null | N | 330018552 | CARBOPLATIN + DOXORUBICIN |
| 330004520 | 330012964 | 0 | null | Palliative (P) | 2014-10-02 | 2014-10-17 | Methotrexate + Folinic acid | 02 | N | 330018552 | CAPE + CARBOPLATIN + CETUXIMAB |
| 330004521 | 330012964 | 1.69 | null | Palliative (P) | null | 2018-05-04 | CHOP | N | N | 330018552 | CARBOPLATIN + DOCETAXEL |
| 330004522 | 330013311 | 1.58 | 67.9 | Curative (C) | 2016-04-20 | 2016-04-20 | CHOP R - 21 days | N | N | 330018571 | CVD |
| 330004523 | 330002190 | 1.72 | 66.8 | Palliative (P) | 2018-04-18 | 2018-04-22 | CETUXIMAB + CISPLATIN + FU | 02 | N | 330018575 | CISPLATIN + DOXORUBICIN + ETOPOSIDE |
| 330004524 | 330007211 | 1.82 | 92.4 | Disease modification (D) | 2016-10-27 | 2016-10-27 | VAC | N | N | 330018582 | CISPLATIN + FLUOROURACIL + RT |
| 330004525 | 330002191 | 1.7 | 69.9 | Palliative (P) | 2014-08-13 | 2014-08-22 | Azacitidine | N | N | 330018598 | CARBOPLATIN + PEMETREXED |
| 330004526 | 330002191 | 1.66 | 12 | Disease modification (D) | 2015-11-01 | 2015-11-01 | Methotrexate intrathecal | N | N | 330018598 | CARBOPLATIN + RT |
| 330004527 | 330002191 | 1.56 | null | Palliative (P) | 2016-04-21 | 2016-04-21 | RUXOLITINIB | 2 | N | 330018598 | MITOTANE |
| 330004528 | 330002191 | 1.83 | 6.7 | Palliative (P) | 2018-02-04 | 2018-02-11 | Trabectedin | Y | N | 330018598 | CETUXIMAB + CISPLATIN + FU |
| 330004529 | 330002191 | 1.61 | 88 | Palliative (P) | 2014-01-24 | 2014-02-01 | CHLORAMBUCIL + RITUXIMAB | 02 | N | 330018598 | OXALIPLATIN + MDG |
| 330004530 | 330002191 | 1.68 | 52.7 | Palliative (P) | 2018-09-17 | 2018-09-17 | Methotrexate High Dose (3g/m2) | Y | N | 330018598 | CAPECITABINE + CARBOPLATIN |
| 330004531 | 330002192 | null | 79.5 | Palliative (P) | 2018-02-15 | 2018-02-26 | VIDE | N | N | 330018649 | CISPLATIN + DOCETAXEL |
| 330004532 | 330002193 | 1.76 | 96.5 | Adjuvant (A) | 2016-05-25 | 2016-06-05 | CNS LGG 2004 03 vinc weekly+ carbo | N | N | 330018665 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 330004533 | 330002193 | 1.77 | 0 | Curative (C) | null | 2014-07-05 | Mitotane 2g | null | null | 330018665 | ETOPOSIDE + IFOSFAMIDE |
| 330004535 | 330002195 | 1.98 | null | Neo-adjuvant (N) | 2013-10-31 | 2013-11-01 | PACLITAXEL | Y | N | 330018684 | CISPLATIN + FLUOROURACIL + RT |
| 330004536 | 330002196 | 1.57 | 75.2 | Curative (C) | 2015-12-31 | 2015-12-31 | FLAG + Idarubicin | N | N | 330018691 | CARBOPLATIN + VINORELBINE |
| 330004537 | 330002196 | 1.64 | 74.1 | Palliative (P) | 2017-03-17 | 2017-03-29 | Imatinib 400mg | N | N | 330018691 | PEMBROLIZUMAB |
| 330004538 | 330002196 | 1.6 | null | Curative (C) | 2015-04-11 | 2015-04-16 | Vincristine (weekly) | N | N | 330018691 | CAPE + CARBOPLATIN + CETUXIMAB |
| 330004539 | 330002196 | 0 | 89.7 | Curative (C) | 2013-09-25 | 2013-09-25 | IMATINIB | 2 | N | 330018691 | ETOPOSIDE + RITUXIMAB |
| 330004540 | 330002197 | 1.56 | 62.1 | Curative (C) | 2014-06-19 | 2014-06-19 | Dacarbazine | 02 | N | 330018707 | VIDE |
| 330004541 | 330002198 | 1.83 | 69.9 | Disease modification (D) | 2018-09-04 | 2018-09-11 | CARBOPLATIN + CETUXIMAB + FU | N | N | 330018709 | CYTARABINE |
| 330004542 | 330002199 | 1.82 | null | Palliative (P) | 2015-02-20 | 2015-02-25 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 330018720 | CAV |
| 330004543 | 330002199 | 1.46 | 64 | Curative (C) | 2016-03-06 | 2016-03-09 | Hydroxycarbamide | 02 | N | 330018720 | CISPLATIN + DOCETAXEL |
| 330004544 | 330002199 | null | 8.2 | null | 2017-07-08 | 2017-07-08 | Hydroxycarbamide | N | null | 330018720 | AZACITIDINE |
| 330004545 | 330002199 | 1.63 | 49 | null | 2015-05-17 | 2015-06-09 | Bexarotene | N | N | 330018720 | CAPECITABINE + RT |
| 330004547 | 330002201 | 1.77 | 72.6 | Palliative (P) | null | 2015-01-24 | R Chlorambucil | N | N | 330018739 | CYCLOPHOSPHAMIDE + LENALIDOMIDE |
| 330004548 | 330002201 | 1.68 | 73.5 | Curative (C) | 2013-03-08 | 2013-03-08 | CHLORAMBUCIL + prednisolone | N | N | 330018739 | AML19 TRIAL |
| 330004549 | 330002202 | 1.82 | 71.4 | Palliative (P) | 2016-08-31 | 2016-08-31 | Vinblastine | N | N | 330018777 | CARBOPLATIN + CETUXIMAB + FU |
| 330004550 | 330002203 | null | 52.6 | Palliative (P) | null | 2014-08-19 | Temozolomide + RT | null | null | 330018785 | ADE |
| 330004551 | 330002203 | 0 | 22.6 | Disease modification (D) | 2015-05-28 | 2015-05-29 | Bendamustine +/- Prednisolone | null | null | 330018785 | FLUOROURACIL + MITOMYCIN + RT |
| 330004552 | 330002203 | null | 75.8 | Curative (C) | 2014-02-13 | 2014-02-14 | ALL UKALL2011 Ind A Std Dex (PAsp) | N | N | 330018785 | AZACITIDINE |
| 330004553 | 330002203 | null | 58.2 | Palliative (P) | 2015-10-24 | 2015-10-29 | Ifosfamide PVI 1g/m2 14day | 99 | N | 330018785 | CARBOPLATIN + VINCRISTINE |
| 330004554 | 330002203 | null | 105 | Palliative (P) | 2018-05-26 | 2018-05-30 | EpSSG NRSTS 2005 | 02 | N | 330018785 | DECITABINE |
| 330004555 | 330002203 | 1.68 | 42.3 | null | 2013-03-04 | 2013-03-06 | Doxorubicin + Ifosfamide | 2 | null | 330018785 | MITOTANE |
| 330004556 | 330012965 | 1.75 | 77.95 | Palliative (P) | 2016-07-24 | 2016-07-29 | Azacitidine | N | N | 330018824 | R-EPOCH |
| 330004557 | 330012965 | null | 104.1 | Curative (C) | 2014-06-19 | 2014-06-19 | FCR | N | null | 330018824 | FLAG + IDARUBICIN |
| 330004558 | 330002204 | 1.77 | 13.2 | Palliative (P) | 2013-05-18 | 2013-06-03 | BCG Intravesical | N | N | 330018834 | BORTEZOMIB |
| 330004559 | 330002205 | null | null | Curative (C) | 2015-11-10 | 2015-11-10 | Bortezomib +/- Dexamethasone | Y | N | 330018835 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 330004560 | 330002205 | 1.56 | 63 | Palliative (P) | null | 2017-09-16 | CHOP R - 21 days | null | null | 330018835 | DOXORUBICIN + OLARATUMAB |
| 330004563 | 330009915 | 1.85 | 61.7 | Curative (C) | 2015-01-28 | 2015-02-02 | Capecitabine + Cisplatin | 02 | N | 330018889 | CISPLATIN + DOX + ETOPOSIDE |
| 330004566 | 330002209 | 0 | null | Curative (C) | null | 2014-04-20 | RUXOLITINIB | null | null | 330018906 | EPIRUBICIN |
| 330004567 | 330002210 | 1.72 | 89 | Palliative (P) | 2015-10-03 | 2015-10-05 | CARBOPLATIN + RT | 02 | N | 330018923 | MITOMYCIN |
| 330004568 | 330007220 | 0 | 72 | Curative (C) | 2015-04-08 | 2015-04-26 | Cetuximab +Cisplatin + FU (Cycle 1) | 02 | N | 330018940 | VINBLASTINE |